{
    "RADCURE-0497": {
        "question": "Age: 75.4, Sex: Male, ECOG PS: ECOG 0, Smoking PY: 5, Smoking Status: Ex-smoker, Ds Site: Oropharynx, Subsite: Base of Tongue, T: T2, N: N2c, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: positive, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-positive cases. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The CT scan is of the head and neck region, with two bounding boxes provided:\n   - Box 1: [268, 167, 98, 268, 201, 116]\n   - Box 2: [257, 226, 129, 257, 261, 157]\n\n2. The coordinates are normalized relative to the image size, indicating specific volumetric regions of interest (ROIs).\n\n3. The first bounding box appears to be located in the mid to lower neck region, possibly encompassing part of the oropharynx or hypopharynx, given the z and y coordinates.\n\n4. The second bounding box is located more inferiorly and laterally, possibly involving lymph node regions or adjacent soft tissues.\n\n5. From a radiation oncology perspective, these ROIs could represent:\n   - Primary tumor sites (e.g., oropharyngeal squamous cell carcinoma)\n   - Involved lymph nodes (nodal metastases)\n   - Critical organs at risk (OARs) such as the spinal cord, parotid glands, or pharyngeal constrictors\n\n6. Without contrast enhancement or further clinical data, it is difficult to definitively identify the structures, but the presence of multiple ROIs suggests tumor and nodal involvement.\n\n7. The pattern of involvement and location is consistent with head and neck squamous cell carcinoma, possibly HPV-related if in the oropharynx.\n\n8. From a survival probability standpoint, involvement of multiple nodal regions or bulky disease in these areas would influence staging and prognosis.\n\n9. Treatment planning would focus on delivering curative radiation doses to these ROIs while sparing critical structures.\n\nFinal answer:  \nAnswer:Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: no\nReason: All necessary expertise for HPV+ head/neck radiation planning is covered.\n---",
        "Round 2-role-comment": "radiation oncologist:alive",
        "Round 2-num_agents": 1,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}